Search hospitals > Ohio > Cleveland

Rainbow Babies and Childrens Hospital

Claim this profile
Cleveland, Ohio 44106
Global Leader in Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Cystic Fibrosis
Conducts research for Fibrosing Colonopathy
Conducts research for Brain Tumor
356 reported clinical trials
16 medical researchers
Photo of Rainbow Babies and Childrens Hospital in ClevelandPhoto of Rainbow Babies and Childrens Hospital in Cleveland

Summary

Rainbow Babies and Childrens Hospital is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Adult T-Cell Leukemia/Lymphoma, Cystic Fibrosis, Fibrosing Colonopathy, Brain Tumor and other specialties. Rainbow Babies and Childrens Hospital is involved with conducting 356 clinical trials across 618 conditions. There are 16 research doctors associated with this hospital, such as Duncan S. Stearns, Michele C Walsh, MD MS, Alex Gifford, MD, and Sanjay Ahuja, MD, MSc, MBA.

Area of expertise

1Cancer
Global Leader
Rainbow Babies and Childrens Hospital has run 59 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Adult T-Cell Leukemia/Lymphoma
Global Leader
Rainbow Babies and Childrens Hospital has run 53 trials for Adult T-Cell Leukemia/Lymphoma. Some of their research focus areas include:
Stage II
Stage IV
Stage III

Top PIs

Clinical Trials running at Rainbow Babies and Childrens Hospital

Brain Tumor
Testicular cancer
Acute Lymphoblastic Leukemia
Cystic Fibrosis
Cancer
Testicular Carcinoma
Adult T-Cell Leukemia/Lymphoma
Germ Cell Tumors
Ovarian Carcinoma
Ovarian Tumors
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria
Image of trial facility.

Chemotherapy + Radiation Therapy

for Brain Cancer

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting1 award Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Rainbow Babies and Childrens Hospital?
Where is Rainbow Babies and Childrens Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Rainbow Babies and Childrens Hospital accept?
What awards or recognition has Rainbow Babies and Childrens Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security